What impact will climate change have on vector-borne diseases? Discover more about rapid environmental and climate changes and the the distribution of vector-borne diseases in future.
The manipulation of public opinion against lifesaving medicine and scientific facts is becoming an increasingly dangerous problem, but what can the science community do to convince people of the truth?
The outbreak of Ebola in the Democratic Republic of Congo has seen over 2612 cases and 1756 mortalities since it was first announced by the WHO on 1 August 2018. One year on we ask, what have the major milestones been of this outbreak? And where are we now; is there an end in sight?
Based on the demonstrated potential of laser-induced vapor nanobubbles to treat bacterial biofilm infections, we provide recommendations for future work in order to further mature this new technology into a promising anti-biofilm approach.
Antibiotic tolerance significantly reduces antibiotic efficacy and contributes to treatment failure; targeting both antibiotic tolerance and antibiotic resistance is critical to develop new antimicrobial strategies that will successfully eradicate hard-to-treat infections.
In line with World Immunization Week, we’ve brought together a panel of experts to discuss the issues surrounding vaccine confidence in a ‘post-truth’ world.
Could the development of products that produce a constant level of exogenous Reactive Oxygen® be beneficial in preventing and treating polymicrobial wound infections? Discover the potential of this avenue for multi-drug resistant organisms and more in our latest opinion piece.
Dr. Suvanand Sahu, Deputy Executive Director, at the Stop TB Partnership, reflects on the UNHLM on TB outlining the progress that was made and what more needs to be done.
Recently, many programs developing respiratory syncytial virus vaccines have sought to vaccinate pregnant women in an effort to enhance maternal immunity. Find out about the challenges and the latest developments.
Vaccination during pregnancy provides important benefits, so why are pregnant women excluded from clinical trials? Learn more about the path towards including this group in vaccine development for both routine and emergency vaccinations.